Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Industry	652.74M	1.01B	1.03B	1.21B	1.11B
Pharmaceutical Industry Growth	-35.08%	-2.68%	-14.96%	9.17%	-45.18%
Unallocated Others	7.68M	12.98M	17.05M	-	-
Unallocated Others Growth	-40.81%	-23.87%	-	-	-
Total	660.42M	1.02B	1.05B	1.21B	1.11B
Total Growth	-35.15%	-3.03%	-13.55%	9.17%	-45.18%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
North East China	44.99M	73.37M	76.83M	88.45M	112.41M
North East China Growth	-38.68%	-4.51%	-13.14%	-21.31%	-55.68%
North China	92.04M	145.67M	170.13M	248.84M	198.77M
North China Growth	-36.82%	-14.38%	-31.63%	25.19%	-39.03%
East China	208.48M	293.75M	347.30M	390.03M	383.25M
East China Growth	-29.03%	-15.42%	-10.95%	1.77%	-34.39%
Central South China	205.08M	326.86M	259.11M	333.28M	284.94M
Central South China Growth	-37.26%	26.15%	-22.25%	16.96%	-51.61%
South West China	58.53M	114.18M	124.46M	88.64M	73.70M
South West China Growth	-48.74%	-8.26%	40.41%	20.26%	-59.80%
North West China	46.49M	61.07M	62.69M	61.08M	47.22M
North West China Growth	-23.88%	-2.58%	2.64%	29.35%	-35.69%
Regional and Export Business	4.81M	3.46M	9.63M	4.50M	12.45M
Regional and Export Business Growth	38.99%	-64.10%	114.22%	-63.87%	-38.44%
Total	660.42M	1.02B	1.05B	1.21B	1.11B
Total Growth	-35.15%	-3.03%	-13.55%	9.17%	-45.18%

Source: S&P Global Market Intelligence.